इसराइल - हिब्रू - Ministry of Health

padagis israel agencies ltd, israel - sulphamethoxazole; trimethoprim - תמיסה לאינפוזיה - sulphamethoxazole 400 mg / 5 ml; trimethoprim 80 mg / 5 ml - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - bacterial infections of respiratory tract, gastrointestinal tracts and skin, susceptible to the drug.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 5 mg/ml - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - abacavir as sulfate - תמיסה (פומי) - abacavir as sulfate 20 mg/ml - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected adults and children.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - adefovir dipivoxil - טבליה - adefovir dipivoxil 10 mg - adefovir dipivoxil - adefovir dipivoxil - hepsera is indicated for the treatment of chronic hepatitis b in adults with evidence of hepatitis b viral replication. reductions in viral replication and improvements in liver function have also been demonstrated in supportive studies in a limited number of chronic hepatitis b patients with genotypic evidence of lamivudine-resistance, including patients with compensated or decompensated liver disease and patients co-infected with hiv.

इसराइल - हिब्रू - Ministry of Health

lapidot medical import and marketing ltd - anti-d immunoglobulins 5000 iu/vial - powder for solution for injection - anti-d (rh) immunoglobulin - prevention of the hemolytic disease of the newborn and treatment of immune thrombocytopenic purpura (itp).

इसराइल - हिब्रू - Ministry of Health

medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 5 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis and invasive haemophilus influenzae type b infection.

इसराइल - हिब्रू - Ministry of Health

medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 20 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis, poliomyelitis and invasive haemophilus influenzae type b infections.

इसराइल - हिब्रू - Ministry of Health

medici medical ltd, israel - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); pertactin; pertussis acellular; tetanus toxoid - תרחיף להזרקה - pertussis acellular 10 mcg / 0.5 ml; filamentous haemagglutinin (fha) 5 mcg / 0.5 ml; fimbrae tupes 2 + 3 (fim) 5 mcg / 0.5 ml; pertactin 3 mcg / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml - pertussis, purified antigen, combinations with toxoids - pertussis, purified antigen, combinations with toxoids - is indicated for the primary immunization of infants at or above the age of 2 months and as a booster in children up to their 6th birthday against diphtheria, tetanus and pertussis.

इसराइल - हिब्रू - Ministry of Health

bioavenir ltd, israel - paclitaxel - תמיסה להזרקה - paclitaxel 6 mg/ml - paclitaxel - paclitaxel - paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. for the treatment of metastatic breast cancer after failure of combination chemotherapy. prior therapy should have included an anthracycline unless clinically contraindicated. advanced non small cell lung cancer: paclitaxel, associated with cisplatium is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. keposi's sarcoma: paclitaxel is indicated in the second- line treatment of aid's related kaposi's sarcoma.paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.for the treatment of advanced gastric carcinoma.

इसराइल - हिब्रू - Ministry of Health

medici ltd - bcg 81 mg/vial - powder for reconstitution - bcg vaccine - for the treatment of superficial transitional cell carcinoma (tcc) of the urinary bladder, regardless of antecedent intravesical treatment superficial tcc comprises the following: carcinoma in situ (cis), papillary tumors limited to the mucosa (stage ta), papillary tumors invoiving the lamina propria but not the muscle layer of the bladder (stage t1), or any combination thereof. immucyst is indicated for treatment and prophylaxis of primary or recurrent carcinoma insitu (cis) of the urinary bladder and for prophylaxis following trans-urethral resection (tur) of primary or recurrent stage ta and/or t1 papilary tumors.